← All trials
NCT04790305
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 18, 2021
- Primary completion
- Dec 31, 2027
- Completion date
- Jul 28, 2028
- First posted
- Mar 10, 2021
- Last posted
- Jul 21, 2021
- Enrollment
- 1072
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Fudan UniversityLead sponsor
- Fudan UniversityReponsible party - principal investigator
- Fudan UniversityOverall official - principal investigator
- Huazhong University of Science and TechnologyCollaborator
- LinkDoc Technology (Beijing) Co. Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.